SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK
If you purchased or acquired securities in GSK between February 5, 2020 and August 14, 2022 and would like to discuss your ...
Pharmabiz12h
Sobi & Apellis Pharma announces EMA validates indication extension application for Aspaveli for treatment of C3G and primary IC-MPGN
Stockholm, Sweden Saturday, February 22, 2025, 09:00 Hrs [IST] ...
Gilead’s lenacapavir under priority review could revolutionise HIV PrEP
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application ...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive ...
EURACTIV21h
Flu cases skyrocket in Poland, causing medicine shortages, rising fatalities
Poland is recording at least three times more flu cases than a year ago. Since the start of the flu season in September, an ...
GlobalData on MSN22h
J&J’s fully subcutaneous Tremfya shows 27.6% clinical remission in UC
Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate to severe UC patients.
PipelineReview.com6h
Gilead’s Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis
Approved, Seladelpar Can Provide an Important Treatment Option for People Living With the Rare Liver Disease in the European Economic Area – ...
Cell And Gene Therapies In Rare Disorders Market To Skyrocket Across The 7MM During The Forecast Period (2025–2034) | Delveinsight
The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...
MeiraGTx rises after publication of positive data from gene therapy trial for eye disorder
MeiraGTx stock rose after publishing promising results from the first human trial using gene therapy to treat ...
Tuko on MSN9h
Ukraine's earth riches are rare and difficult to reach
Ukraine's soils hold some five percent of the world's mineral resources, which is what US President Donald Trump is anxious to secure, but not all of them are yet exploited -- or maybe even ...